Brokerages Set Simulations Plus, Inc. (NASDAQ:SLP) Target Price at $60.67

Simulations Plus, Inc. (NASDAQ:SLPGet Rating) has been assigned an average recommendation of “Buy” from the seven brokerages that are currently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $60.67.

Several equities analysts recently weighed in on the stock. StockNews.com assumed coverage on shares of Simulations Plus in a report on Thursday, March 31st. They issued a “hold” rating on the stock. Zacks Investment Research lowered shares of Simulations Plus from a “buy” rating to a “hold” rating in a report on Thursday, March 10th. Finally, Sidoti began coverage on shares of Simulations Plus in a report on Tuesday, January 4th. They issued a “neutral” rating on the stock.

SLP opened at $50.93 on Thursday. The company’s 50 day simple moving average is $43.76 and its 200-day simple moving average is $45.42. Simulations Plus has a one year low of $35.18 and a one year high of $70.50. The stock has a market capitalization of $1.03 billion, a P/E ratio of 92.60 and a beta of 0.26.

Simulations Plus (NASDAQ:SLPGet Rating) last announced its quarterly earnings data on Wednesday, April 6th. The technology company reported $0.21 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.14 by $0.07. Simulations Plus had a net margin of 23.13% and a return on equity of 6.86%. During the same period last year, the company earned $0.15 EPS. As a group, sell-side analysts anticipate that Simulations Plus will post 0.63 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Monday, May 2nd. Shareholders of record on Monday, April 25th will be issued a $0.06 dividend. The ex-dividend date of this dividend is Friday, April 22nd. This represents a $0.24 annualized dividend and a yield of 0.47%. Simulations Plus’s dividend payout ratio (DPR) is presently 43.64%.

In related news, Director Walter S. Woltosz sold 14,333 shares of the firm’s stock in a transaction on Thursday, February 24th. The shares were sold at an average price of $37.67, for a total transaction of $539,924.11. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Walter S. Woltosz sold 15,140 shares of the firm’s stock in a transaction on Tuesday, March 29th. The stock was sold at an average price of $48.55, for a total transaction of $735,047.00. The disclosure for this sale can be found here. Over the last quarter, insiders sold 50,073 shares of company stock worth $2,085,827. Company insiders own 23.08% of the company’s stock.

Several large investors have recently modified their holdings of SLP. Conestoga Capital Advisors LLC raised its holdings in shares of Simulations Plus by 45.5% during the fourth quarter. Conestoga Capital Advisors LLC now owns 2,223,168 shares of the technology company’s stock worth $105,156,000 after acquiring an additional 695,406 shares during the period. Neuberger Berman Group LLC grew its position in Simulations Plus by 16.0% in the third quarter. Neuberger Berman Group LLC now owns 1,593,619 shares of the technology company’s stock valued at $62,948,000 after purchasing an additional 219,631 shares in the last quarter. State Street Corp grew its position in Simulations Plus by 25.1% in the fourth quarter. State Street Corp now owns 676,898 shares of the technology company’s stock valued at $32,017,000 after purchasing an additional 135,801 shares in the last quarter. State of Michigan Retirement System bought a new position in Simulations Plus in the fourth quarter valued at $5,591,000. Finally, Ranger Investment Management L.P. grew its position in Simulations Plus by 12.3% in the fourth quarter. Ranger Investment Management L.P. now owns 882,164 shares of the technology company’s stock valued at $41,726,000 after purchasing an additional 96,272 shares in the last quarter. Institutional investors and hedge funds own 75.17% of the company’s stock.

Simulations Plus Company Profile (Get Rating)

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft.

Recommended Stories

Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.